Dental Products and Equipment Registration under NT 29 in Guatemala
Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Dental products and equipment in Guatemala follow a standalone technical standard: Norma Técnica 29, Versión 2-2015, Inscripción sanitaria de productos y equipos odontológicos (sanitary registration of dental products and equipment), with an update date of 2015-10-08. It does not share the classification table of NT-37, nor the risk tiers of NT-40, but forms a third set of registration rules of its own. Dental consumables and dental equipment should therefore be planned under NT-29 rather than by forcing them into the four-class device scheme. For any dental portfolio entering Guatemala, identifying the applicable standard is the first act of the project, and everything downstream — the document list, the format, the review expectations — follows from that single choice. The three-channel structure is not an oversight but a deliberate design, and it rewards applicants who read the dental standard on its own terms instead of assuming the device framework extends by analogy. It also means a dental submission is judged by dental expectations at the window, so a dossier drafted from the device template will be visibly out of place from the first page.
2. Legal basis
The three parallel standards and the exemption list that cuts across them are set out below. The table is worth reading column by column: the versions and dates differ across the three channels, and only the dental standard carries an update date, which is one of the details that makes a unified ledger format useful.
| Instrument | Number / version / date | Key points |
| NT 29, sanitary registration of dental products and equipment | Versión 2-2015, updated 2015-10-08 | collected in the current-text section under Normas Técnicas on the MSPAS website, and read as the governing instrument for the dental category |
| NT 37, sanitary registration of medical devices | Versión 5-2016, 2016-02-22 | the main device channel, with Annex 1 as the classification table |
| NT 40, sanitary registration of in vitro diagnostic reagents | Versión 3-2015 | the reagent channel |
| NT 37, Annex 2 | 2016-02-22 | the exemption list includes dental treatment units, light-curing lamps, dental handpieces, amalgamators, dental X-ray machines and more |
3. Expert insights
Insight one: three standards run in parallel, so the standard is chosen before any document is drafted. Guatemala manages related products by category, each with its own standard: devices follow NT-37, reagents follow NT-40, dental products follow NT-29. Choosing the wrong standard means the document list is misaligned from the very first item, and the misalignment is usually discovered late, when the dossier is already assembled. The first task at project initiation is to determine the applicable standard, not to start collecting documents.
Insight two: dental equipment and dental consumables are treated differently in Annex 2. The NT-37 Annex 2 exemption list contains dental equipment such as dental treatment units, light-curing lamps, dental handpieces, amalgamators and dental X-ray machines, but dental consumables are not on it. This shows that the line of equipment exempt and consumables registered holds in the dental field as well, and an entire dental product line cannot be treated as registration-exempt as a block. A dental catalogue therefore needs to be split before any filing plan is made: the durable chairs, lamps, handpieces and imaging units go to the Annex 2 comparison, while the restorative and surgical consumables go straight to the NT-29 registration plan.
Insight three: sterility and the mode of contact still matter for dental products. NT-29 stands apart from NT-37, but where a product also carries device attributes — such as dental implants or dental suture materials — the attribution judgement must be made between NT-29 and NT-37 and supported by a written rationale. These crossover products are the ones most often asked to provide further explanation at the review stage. Preparing the rationale once, well, is far cheaper than assembling it under deadline after a review query arrives.
Insight four: the update date and the effective date of a standard must be recorded separately. NT-29 records an update date of 2015-10-08, which is a different manner of recording from the NT-37 wording that the standard takes effect from the day of publication on the website (Article 14). Treating the two dates as interchangeable invites exactly the kind of version confusion the ledger is meant to prevent. Keeping three separate entries in the ledger for each standard — version, update date and effective-date wording — prevents version-checking errors, because the three values do not move together and cannot be reconstructed from one another.
4. Practical recommendations
- At project initiation, determine the applicable standard first — NT-37 for devices, NT-40 for reagents, NT-29 for dental — and keep a written record of the choice among the three, citing the product characteristics that drove it.
- Plan registration for dental consumables under NT-29, and for dental equipment compare against the NT-37 Annex 2 exemption list first, keeping the outcome of the comparison with the product record.
- For products with crossover attributes, such as dental implants, make the attribution judgement between the two standards and prepare the supporting explanation, including the use statements and contact characteristics that inform it.
- Record each standard in the ledger under three separate entries: version, update date and effective-date wording, so that any reviewer can verify the current status without re-deriving it.
- Before submission, check the current-text section of the MSPAS website to confirm that NT-29 remains the current version, and note the date of that check in the project file.
5. Verification checklist
- □ The applicable standard has been determined as NT-29, NT-37 or NT-40
- □ Dental consumables are planned for registration under NT-29
- □ Dental equipment has been compared against the NT-37 Annex 2 exemption list
- □ Crossover products have completed the attribution judgement with the explanation prepared
- □ The ledger records version, update date and effective-date wording as three entries
- □ The current text on the MSPAS website has been checked
Regulatory information verified as of 29 October 2026.
How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Guatemalan market. Our team manages Ministry of Public Health and Social Assistance (MSPAS) registrations, coordinates import and distributor requirements, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us